Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

N-able (NABL) Beats Q2 Earnings and Revenue Estimates
N-able (NABL) Beats Q2 Earnings and Revenue Estimates

N-able (NABL) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.14 per share a year ago. These figures are

D-Wave Quantum Inc. (QBTS) Reports Q2 Loss, Beats Revenue Estimates
D-Wave Quantum Inc. (QBTS) Reports Q2 Loss, Beats Revenue Estimates

D-Wave Quantum Inc. (QBTS) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.1 per share a year ago. These

Insulet (PODD) Surpasses Q2 Earnings and Revenue Estimates
Insulet (PODD) Surpasses Q2 Earnings and Revenue Estimates

Insulet (PODD) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.55 per share a year ago. These figures

Kimbell Royalty (KRP) Lags Q2 Earnings Estimates
Kimbell Royalty (KRP) Lags Q2 Earnings Estimates

Kimbell Royalty (KRP) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.11 per share a year ago. These

C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates

C4 Therapeutics, Inc. (CCCC) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $0.26 per share a year ago. These

Crocs (CROX) Q2 Earnings and Revenues Surpass Estimates
Crocs (CROX) Q2 Earnings and Revenues Surpass Estimates

Crocs (CROX) came out with quarterly earnings of $4.23 per share, beating the Zacks Consensus Estimate of $4.01 per share. This compares to earnings of $4.01 per share a year ago. These figures are

Datadog (DDOG) Surpasses Q2 Earnings and Revenue Estimates
Datadog (DDOG) Surpasses Q2 Earnings and Revenue Estimates

Datadog (DDOG) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.43 per share a year ago. These figures

Energy Transfer Q2 Earnings In Line With Estimates, Revenues Down Y/Y
Energy Transfer Q2 Earnings In Line With Estimates, Revenues Down Y/Y

Energy Transfer ET reported second-quarter 2025 adjusted earnings of 32 cents per unit, in line with the Zacks Consensus Estimate. The bottom line decreased 8.6% from the year-ago figure of 35

e.l.f. Beauty Q1 Earnings Beat Estimates, Sales Rise 9% Y/Y
e.l.f. Beauty Q1 Earnings Beat Estimates, Sales Rise 9% Y/Y

e.l.f. Beauty, Inc. (ELF) reported results for the first-quarter fiscal 2026, wherein both top and bottom lines beat the Zacks Consensus Estimate. While net sales increased, earnings decreased from

Barrick Mining to Post Q2 Earnings: What's in the Cards for the Stock?: https://pixabay.com/de/photos/gold-ingots-golden-schatz-513062/
Barrick Mining to Post Q2 Earnings: What's in the Cards for the Stock?

Barrick Mining Corporation B is slated to come up with second-quarter 2025 results before the opening bell on Aug. 11. The gold mining giant beat the Zacks Consensus Estimate for earnings in three

Apple Jumps 5.1% After $100 Billion U.S. Manufacturing Pledge
Apple Jumps 5.1% After $100 Billion U.S. Manufacturing Pledge

Apple Inc.'s AAPL shares soared 5.1% on Aug. 6, 2025, marking one of the most notable gains among major tech companies and driving a broader market rally. The sharp uptick came after a White House

Warner Bros. Discovery (WBD) Surpasses Q2 Earnings Estimates
Warner Bros. Discovery (WBD) Surpasses Q2 Earnings Estimates

Warner Bros. Discovery (WBD) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of a loss of $0.16 per share. This compares to a loss of $4.07 per share a year

SolarEdge Technologies (SEDG) Reports Q2 Loss, Beats Revenue Estimates
SolarEdge Technologies (SEDG) Reports Q2 Loss, Beats Revenue Estimates

SolarEdge Technologies (SEDG) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.82. This compares to a loss of $1.79 per share a year ago. These

Hyatt Hotels (H) Beats Q2 Earnings and Revenue Estimates
Hyatt Hotels (H) Beats Q2 Earnings and Revenue Estimates

Hyatt Hotels (H) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $1.53 per share a year ago. These figures

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates

Phathom Pharmaceuticals, Inc. (PHAT) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to a loss of $1.25 per share a year ago

Evergy Inc (EVRG) Q2 Earnings Surpass Estimates
Evergy Inc (EVRG) Q2 Earnings Surpass Estimates

Evergy Inc (EVRG) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.9 per share a year ago. These figures

Cogent Communications (CCOI) Reports Q2 Loss, Beats Revenue Estimates
Cogent Communications (CCOI) Reports Q2 Loss, Beats Revenue Estimates

Cogent Communications (CCOI) came out with a quarterly loss of $1.21 per share versus the Zacks Consensus Estimate of a loss of $0.93. This compares to a loss of $0.75 per share a year ago. These

Post Q2 Earnings, Is Chevron a Name to Watch or One to Chase?
Post Q2 Earnings, Is Chevron a Name to Watch or One to Chase?

Chevron Corporation’s CVX second-quarter earnings beat Zacks Consensus Estimate, but the broader narrative remains layered. While adjusted EPS of $1.77 topped the Zacks Consensus Estimate of $1.70

Viatris (VTRS) Tops Q2 Earnings and Revenue Estimates
Viatris (VTRS) Tops Q2 Earnings and Revenue Estimates

Viatris (VTRS) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.69 per share a year ago. These figures

Warby Parker Inc. (WRBY) Q2 Earnings Match Estimates
Warby Parker Inc. (WRBY) Q2 Earnings Match Estimates

Warby Parker Inc. (WRBY) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.06 per share a year ago. These figures are

US Foods (USFD) Tops Q2 Earnings Estimates
US Foods (USFD) Tops Q2 Earnings Estimates

US Foods (USFD) came out with quarterly earnings of $1.19 per share, beating the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $0.93 per share a year ago. These figures

Martin Marietta (MLM) Surpasses Q2 Earnings Estimates
Martin Marietta (MLM) Surpasses Q2 Earnings Estimates

Martin Marietta (MLM) came out with quarterly earnings of $5.43 per share, beating the Zacks Consensus Estimate of $5.32 per share. This compares to earnings of $5.26 per share a year ago. These

Thermon Group (THR) Q1 Earnings and Revenues Miss Estimates
Thermon Group (THR) Q1 Earnings and Revenues Miss Estimates

Thermon Group (THR) came out with quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.38 per share a year ago. These

Janus International Group, Inc. (JBI) Q2 Earnings and Revenues Beat Estimates
Janus International Group, Inc. (JBI) Q2 Earnings and Revenues Beat Estimates

Janus International Group, Inc. (JBI) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.21 per share a year

Aclaris Therapeutics (ACRS) Reports Q2 Loss, Beats Revenue Estimates
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Beats Revenue Estimates

Aclaris Therapeutics (ACRS) came out with a quarterly loss of $0.13 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.15 per share a year ago. These figures are